Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

16.29

-0.19 (-1.15%)

At close: Aug 28, 2026, 4:00 PM EDT

16.35

+0.06 (0.37%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Aurinia Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,167	2,103	1,286	1,291	614	2,966
Market Cap Growth	35.97%	63.55%	-0.41%	110.30%	-79.30%	69.42%
Enterprise Value	1,789	1,830	1,025	1,047	246	2,688
Last Close Price	16.29	15.95	8.98	8.99	4.32	22.87

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	7.07	7.32	223.53	-	-	-
Forward PE	20.88	19.69	24.06	-	-	-
PS Ratio	6.96	7.43	5.47	7.36	4.58	65.03
PB Ratio	3.52	3.62	3.41	3.42	1.51	6.19
P/TBV Ratio	3.54	3.64	3.45	3.46	1.54	6.30
P/FCF Ratio	12.38	15.53	29.15	-	-	-
P/OCF Ratio	12.37	15.50	28.97	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.74	6.46	4.36	5.97	1.84	58.94
EV/EBITDA Ratio	9.95	13.48	32.08	-	-	-
EV/EBIT Ratio	11.15	15.74	81.91	-	-	-
EV/FCF Ratio	10.22	13.51	23.25	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.10	0.13	0.21	0.26	0.02	0.02
Debt / EBITDA Ratio	0.36	0.55	2.42	-	-	-
Debt / FCF Ratio	0.37	0.55	1.80	-	-	-
Net Debt / Equity Ratio	-0.62	-0.56	-0.74	-0.67	-0.94	-0.95
Net Debt / EBITDA Ratio	-2.11	-2.38	-8.73	3.41	3.51	2.57
Net Debt / FCF Ratio	-2.16	-2.39	-6.33	7.40	4.78	2.89
Asset Turnover	0.48	0.44	0.43	0.35	0.26	0.09
Inventory Turnover	1.50	1.54	1.24	1.98	2.30	3.14
Quick Ratio	4.86	4.70	4.05	4.86	8.76	11.84
Current Ratio	5.42	5.25	4.57	5.50	9.60	12.63
Return on Equity (ROE)	66.12%	59.91%	1.52%	-19.92%	-24.46%	-40.81%
Return on Assets (ROA)	15.49%	11.16%	1.42%	-10.53%	-13.74%	-22.43%
Return on Invested Capital (ROIC)	65.00%	65.20%	8.65%	-114.84%	-482.28%	-907.37%
Return on Capital Employed (ROCE)	23.20%	17.70%	2.80%	-18.20%	-26.20%	-36.00%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	14.49%	13.66%	0.45%	-6.04%	-17.62%	-6.10%
FCF Yield	8.08%	6.44%	3.43%	-2.65%	-13.00%	-5.33%
Buyback Yield / Dilution	5.66%	5.13%	-2.07%	-0.93%	-9.70%	-9.20%

SEC Filings: 10-K · 10-Q